-+ 0.00%
-+ 0.00%
-+ 0.00%

CAPR Deadline Alert: SueWallSt Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026

Barchart·08/13/2026 11:37:00
Listen to the news

A securities class action alleges Capricor Therapeutics did not follow the pre-specified blinding and protocol procedures for its Phase 3 HOPE-3 trial, with FDA later noting that the final study protocol deviated from the associated statistical analysis plan.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.